Besides revealing a cell-of-origin signature reflected in the methylation pattern of a tumor, epigenetic profiling also proved powerful in predicting the occurrence of genetic drivers in some tumor entities (e.g. CpG island methylator phenotype (CIMP) in IDH mutant gliomas) [19]. This evidence concerns the gene IDH1 and central nervous system cancer.